Senior Director, Investor Relations

Role Summary

The Senior Director of Investor Relations will lead Cytokinetics’ investor relations strategy and execution, partnering with the SVP of Corporate Affairs and the executive leadership team to communicate the company’s business strategy, financial performance, and long-term value to the investment community. As the company pivots from R&D to commercialization, this role will guide the investor relations program to communicate progress and leadership in muscle biology research and development. The ideal candidate will have deep pharmaceutical/biotechnology investor relations experience in commercial-stage organizations, strong capital markets acumen, executive presence, and the ability to operate at both strategic and tactical levels.

Responsibilities

• Develop and execute a comprehensive investor relations strategy aligned with corporate objectives and key value inflection points.
• Serve as a trusted advisor to the executive leadership team on investor perception, market dynamics, and capital markets strategy.
• Closely collaborate with Senior Director, Corporate Communications to shape and refine Cytokinetics’ narrative to ensure clarity, differentiation, and consistency across all investor and other communications.
• Partner cross-functionally to anticipate and communicate major milestones, including clinical, regulatory, and commercial developments.
• Lead engagement with buy-side and sell-side analysts, institutional investors, and key stakeholders. Build and cultivate strong relationships with current and potential new investors.
• Prepare senior leadership for earnings calls, investor conferences, non-deal roadshows, and other investor interactions.
• Develop and draft briefing materials, Q&A documents, key messaging, and investor presentations.
• Collaborate with Finance to monitor analyst models, reports, and shareholder base trends; provide actionable insights to executive leadership; engage with analysts to inform consensus.
• Monitor and alert management to market trends, industry developments, competitor activity and investor sentiment; prepare proactive and reactive plans and statements/messages, including course corrections as needed.
• Oversee quarterly earnings process, including script preparation, messaging strategy, and coordination across Finance and Corporate Communications.
• Ensure alignment and accuracy across SEC filings, press releases, investor decks, and website disclosures.
• Partner with Finance and Legal to ensure compliance with disclosure regulations and best practices.

Qualifications

• Bachelor’s degree required in Finance, Accounting, Communications; and/or advanced degree preferred.
• 12+ years of experience in investor relations, equity research, investment banking, or related capital markets roles.
• Significant investor relations experience within the pharmaceutical or biotechnology industry is required, preferably in a publicly traded, commercial-stage company.
• Demonstrated experience working closely with C-suite executives and senior stakeholders.
• Strong understanding of financial and investor markets, accounting principles and regulatory requirements.
• Strong understanding of drug development, regulatory pathways, clinical data interpretation, and commercial dynamics in biotech/pharma.
• Exceptional written and verbal communication skills with the ability to translate complex scientific and financial information into compelling narratives.
• Proven ability to operate strategically while also executing tactically and independently.
• Results-oriented with proven track record for meeting or exceeding goals.
• Proven ability to maintain confidentiality, exercise judgment and discretion.
• High executive presence, sound judgment, and discretion.

Additional Requirements

• Willingness to travel